Investment Stage

Focus Areas

About Investor

Ryan Bethencourt is a Partner at Babel Ventures who focuses on investments in Pharmaceuticals, Food and Beverage, BioTech, and Health & Hospital Services at Pre-seed, Seed, and Series A stages, with investment ranges typically between $100K and $5.0M. His verified work background includes being an American scientist, entrepreneur, and biohacker best known as co-founder and CEO of Wild Earth, Partner at Babel Ventures, and co-founder and former Program Director at IndieBio, a biology accelerator and early stage seed fund. Bethencourt was head of life sciences at the XPRIZE foundation, co-founded Berkeley Biolabs and Halpin Neurosciences, and has worked over the last decade in the biopharmaceutical industry to partner on and develop novel drugs with major biopharmaceutical companies including Pfizer, AZ, J&J, Sanofi, Takeda, Amgen, and Genentech. He has a BSc degree in Biological Sciences (Molecular Genetics) from Warwick University and a joint Masters in Bioscience Enterprise (MBE) from Cambridge.